Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study
Authors:ID Ajjan, Ramzi A. (Author)
ID Battelino, Tadej (Author)
ID Seufert, Jochen (Author)
ID Blin, Patrick (Author)
ID Pouvourville, Gérard de (Author)
ID Vicaut, Eric (Author)
Files:.pdf PDF - Presentation file, download (975,07 KB)
MD5: 30B4D00AFFEC50DCF4CA340E99BFE2B9
 
URL URL - Source URL, visit https://doi.org/10.1136/bmjopen-2024-085961
 
Language:English
Typology:1.03 - Other scientific articles
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Introduction: Glycated haemoglobin (HbA1c) is currently the gold standard for assessing glycaemic control in diabetes, given the established relationship with microvascular and macrovascular complications in this condition. However, HbA1c is affected by non-glycaemic factors, while also failing to provide data on hypoglycaemic exposure and glucose variability, which are associated with adverse vascular outcomes. Continuous glucose monitoring (CGM)-derived glucose metrics provide a more comprehensive assessment of glycaemia, but their role in predicting future vascular complications remains unclear. Here, we present the protocol for a real-world cohort study, aiming to establish the relationship between CGM-derived glycaemic metrics and the incidence of macrovascular and/or microvascular complications in people with diabetes. Methods and analysis: This cohort study will use data from all CGM new users (FreeStyle Libre system) in France who uploaded their glycaemic values onto the LibreView cloud-based system, linked with data from the French nationwide Système National des Données de Santé claims database. The study is expected to include a minimum of 70 000 individuals with diabetes with a first date of glucose data upload to the LibreView platform after 1 January 2018 and with a 6-year follow-up period. The primary outcomes are the first occurrence of new macrovascular or microvascular complications, analysed as a composite outcome and separately. Secondary outcomes will include all-cause mortality and hospital admissions for any cause. This longitudinal study will provide key data on the relationship between CGM-derived glycaemic metrics and micro/macrovascular complications in diabetes. This will have an impact on routine clinical practice by setting targets for the different glycaemic markers, based on robust outcome data, thus helping to optimise glucose management in diabetes. Ethics and dissemination: The study data-collection protocol is approved by the French National Commission for Informatics and Liberties, including approval from the Comité Ethique et Scientifique pour les Recherches, les Etudes et les Evaluations dans le domaine de la Santé. This study complies with French and European regulations, including those relating to the General Data Protection Regulation. This study uses pseudonymous information, not requiring informed consent. Dissemination plans include full publication of the study outcomes in peerreviewed journal(s) with open access and presentations at national and international diabetes and cardiovascular conferences.
Keywords:continuous glucose monitoring, diabetes, cohort study, glycaemic values
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. 1-9
Numbering:Vol. 15, issue 1, [article no.] e085961
PID:20.500.12556/DiRROS-27756 New window
UDC:616.379
ISSN on article:2044-6055
DOI:10.1136/bmjopen-2024-085961 New window
COBISS.SI-ID:251197955 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 1. 10. 2025;
Publication date in DiRROS:24.02.2026
Views:206
Downloads:89
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:BMJ open
Publisher:BMJ Publishing
ISSN:2044-6055
COBISS.SI-ID:30480601 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Back